MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.00 (0.00%)
Close on Nov 13, 2026Market cap $8.56MP/E –Yield –
MetaVia total assets
Total assets on the balance sheet at the end of each period.
MetaVia's total assets was $9.55M at Sep 30, 2026. For fiscal 2025 it was $11.12M, down 31.6% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $33.53M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.12M | -31.6% |
| FY2024 | Dec 31, 2024 | $16.26M | -28.6% |
| FY2023 | Dec 31, 2023 | $22.78M | -32.1% |
| FY2022 | Dec 31, 2022 | $33.53M | +99.6% |
| FY2021 | Dec 31, 2021 | $16.80M | +53.2% |
| FY2020 | Dec 31, 2020 | $10.97M | -24.2% |
| FY2019 | Dec 31, 2019 | $14.47M | +278.7% |
| FY2018 | Dec 31, 2018 | $3.82M | -79.9% |
| FY2017 | Dec 31, 2017 | $19.02M | -23.2% |
| FY2016 | Dec 31, 2016 | $24.75M | +451.3% |
| FY2015 | Dec 31, 2015 | $4.49M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.55M | -35.3% |
| Q2 FY2026 | Jun 30, 2026 | $13.27M | -28.1% |
| Q1 FY2026 | Mar 31, 2026 | $14.39M | +18.6% |
| Q4 FY2025 | Dec 31, 2025 | $11.12M | -31.6% |
| Q3 FY2025 | Sep 30, 2025 | $14.77M | -33.3% |
| Q2 FY2025 | Jun 30, 2025 | $18.46M | -35.8% |
| Q1 FY2025 | Mar 31, 2025 | $12.13M | -28.7% |
| Q4 FY2024 | Dec 31, 2024 | $16.26M | -28.6% |
| Q3 FY2024 | Sep 30, 2024 | $22.15M | -16.2% |
| Q2 FY2024 | Jun 30, 2024 | $28.75M | -1.5% |
| Q1 FY2024 | Mar 31, 2024 | $17.02M | -46.0% |
| Q4 FY2023 | Dec 31, 2023 | $22.78M | -32.1% |
| Q3 FY2023 | Sep 30, 2023 | $26.43M | +249.7% |
| Q2 FY2023 | Jun 30, 2023 | $29.18M | +189.4% |
| Q1 FY2023 | Mar 31, 2023 | $31.49M | +133.9% |
| Q4 FY2022 | Dec 31, 2022 | $33.53M | +99.6% |
| Q3 FY2022 | Sep 30, 2022 | $7.56M | -6.4% |
| Q2 FY2022 | Jun 30, 2022 | $10.08M | -5.9% |
| Q1 FY2022 | Mar 31, 2022 | $13.46M | -4.9% |
| Q4 FY2021 | Dec 31, 2021 | $16.80M | +53.2% |
| Q3 FY2021 | Sep 30, 2021 | $8.08M | -38.8% |
| Q2 FY2021 | Jun 30, 2021 | $10.72M | -31.1% |
| Q1 FY2021 | Mar 31, 2021 | $14.16M | +22.8% |
| Q4 FY2020 | Dec 31, 2020 | $10.97M | -24.2% |
| Q3 FY2020 | Sep 30, 2020 | $13.20M | +544.4% |
| Q2 FY2020 | Jun 30, 2020 | $15.55M | +287.4% |
| Q1 FY2020 | Mar 31, 2020 | $11.54M | +87.3% |
| Q4 FY2019 | Dec 31, 2019 | $14.47M | +278.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.05M | -91.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.01M | -86.1% |
| Q1 FY2019 | Mar 31, 2019 | $6.16M | -82.3% |
| Q4 FY2018 | Dec 31, 2018 | $3.82M | -79.9% |
| Q3 FY2018 | Sep 30, 2018 | $24.87M | -5.1% |
| Q2 FY2018 | Jun 30, 2018 | $28.81M | +25.2% |
| Q1 FY2018 | Mar 31, 2018 | $34.84M | +16.7% |
| Q4 FY2017 | Dec 31, 2017 | $19.02M | -23.2% |
| Q3 FY2017 | Sep 30, 2017 | $26.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $23.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.84M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.75M | – |
See a number that looks wrong?